Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Melissa A, Michelon"'
Autor:
Melissa A Michelon, Alice B Gottlieb
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol 2010, Iss default, Pp 79-84 (2010)
Melissa A Michelon1, Alice B Gottlieb1,21Tufts University School of Medicine, 2Department of Dermatology, Tufts Medical Center, Boston, MA, USAAbstract: Psoriatic arthritis (PsA) is an inflammatory arthritis that affects many psoriasis patients and c
Externí odkaz:
https://doaj.org/article/881711194aee477c8efc126541cb32f6
Autor:
Susan Jacob, Emily Morrison, Nikki A. Levin, Mary Pinkston, Rebecca Ukaegbu, Waldo Zamor, Melissa A Michelon, Holly Neale, April Deng
Publikováno v:
Journal of the American Academy of Dermatology. 87(2)
Autor:
Melissa A Michelon, Andrew Wang
Publikováno v:
Psoriasis Forum. :51-56
Background Golimumab is a new tumor necrosis factor (TNF) antagonist recently approved by the Food and Drug Administration for controlling the signs and symptoms of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis, although it is
Publikováno v:
Dermatology Online Journal. 20
Alternaria species are a group of dematiaceous fungi that are ubiquitous in nature and are becoming an increasingly important cause of disease in immunocompromised patients. We present a case of a 70 year old renal transplant recipient with multiple
Publikováno v:
Journal of drugs in dermatology : JDD. 12(5)
We present a case of a 33-year-old female who was incidentally found to have cutaneous leiomyomata during a routine skin examination. Further history revealed that she also suffered from uterine fibroids and that her mother had died at an early age f
Autor:
Eva M. Volf, Melissa A Michelon, Noori Kim, Andrew C. Wang, Paul F. Lizzul, Israel D. Andrews, Ari M. Goldminz, Shimrat Yaniv, Todd Kerensky, Meghan T. Hession, Alice B. Gottlieb, Nicole Dumont, Shiu-chung Au
Publikováno v:
The Journal of dermatological treatment. 24(3)
Palmoplantar psoriasis is a variant of psoriasis resistant to many forms of treatment.Twenty subjects with moderate-to-severe psoriasis of the palms and soles, 50% with pustules at baseline, were treated with ustekinumab at weeks 0, 4, and 16. All su
Autor:
Alice B. Gottlieb, Todd Kerensky, Noori Kim, Paul F. Lizzul, Ari M. Goldminz, Andrew C. Wang, Trevor E. Davis, Daniel S. Loo, Christina F. Pelajo, Danielle Levine, Marc D. Natter, Melissa A Michelon, Laurie C. Miller, Shimrat Yaniv, Nicole Dumont, Shiu-chung Au, Eva M. Volf, Jorge M. Lopez-Benitez
Publikováno v:
Journal of the American Academy of Dermatology. 66(6)
Autor:
Eva M, Volf, Danielle E, Levine, Melissa A, Michelon, Shiu-Chung, Au, Eshan, Patvardhan, Nicole, Dumont, Daniel S, Loo, Jeffrey, Kuvin, Alice B, Gottlieb
Publikováno v:
Journal of drugs in dermatology : JDD. 10(8)
Adult patients with psoriasis have an increased prevalence of the metabolic syndrome (MetS) and cardiovascular disease (CVD) risk factors due to elevations of Tumor Necrosis Factor and other inflammatory cytokines.1,2 Recently, higher rates of hyperl
Autor:
Bruce F. Bebo, Stefan C. Weiss, Abby S. Van Voorhees, Christopher T. Ritchlin, Lawrence F. Eichenfield, Andrew Blauvelt, Joel M. Gelfand, Jerry Bagel, Linda Stein Gold, Carmen Jacobsen, Sylvia Hsu, Mark Lebwohl, Gerald G. Krueger, Karolyn A. Wanat, Neil J. Korman, Steven R. Feldman, Stephen P. Stone, Kim A. Papp, Arthur Kavanaugh, Robert E. Kalb, Warwick L. Morison, Jeffrey J. Crowley, David Fiorentino, Alice B. Gottlieb, Melissa A Michelon, Kristina Callis Duffin, Bruce Strober
Publikováno v:
Archives of Dermatology. 148:95
The Canadian Guidelines for the Management of Plaque Psoriasis were reviewed by the entire National Psoriasis Foundation Medical Board and updated to include newly approved agents such as ustekinumab and to reflect practice patterns in the United Sta